Jan 09, 2023 / 09:30PM GMT
Xiling Chen - JPMorgan Chase & Co, Research Division - Analyst
Good afternoon, ladies and gentlemen. I'm Cici Chen, China health care analyst here at JPMorgan. And it is my honor today to welcome Mr. John Oyler, BeiGene's CEO and Co-Founder. And with that, I'll pass it away to John.
John V. Oyler - BeiGene, Ltd. - Co-Founder, Executive Chairman & CEO
Terrific. Good afternoon, everyone. I'm John Oyler. As was just mentioned, I'm the CEO and the co-founder of BeiGene. It's great to be here with all of you in person, and I'd like to thank JPMorgan for hosting us today.
I want to start with one thought. BeiGene is a strong global science-driven company that's delivering on our vision to transform or redefine the biotech industry. We're doing this by creating impactful medicines that are affordable and accessible to far more cancer patients around the world.
So today, I don't want to talk so much about the company we're going to become. Instead, I want to talk about the company we are today and what we're doing. In doing so, I want to make
Beigene Ltd at JPMorgan Healthcare Conference Transcript
Jan 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers